Medical Devices

mRNA Vaccines and Therapeutics Market Seeking Excellent Growth | Ethris,Argos Therapeutics,Precision NanoSystems

mRNA Vaccines and Therapeutics Market: Comprehensive study explores Huge Growth in Future

(New Jersey)A new research document is added in HTF MI database of 119 pages, titled as ‘COVID-19 Outbreak-Global mRNA Vaccines and Therapeutics Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020′  with detailed analysis, Competitive landscape, forecast and strategies. The study covers geographic analysis that includes regions like North America, Europe or Asia and important players/vendors such as Ethris,Argos Therapeutics,Precision NanoSystems,Moderna Therapeutics,Bayer,CRISPR Therapeutics,PhaseRx,BioNTech,MaxCyte,eTheRNA immunotherapies,CureVac,Boehringer Ingelheim.The Market has witnessed continuous growth in the past few years and is projected to see some stability post Q2,2020 and may grow further during forecast year 2021-2026

Access sample report @ https://www.htfmarketreport.com/sample-report/2822325-covid-19-outbreak-global-mrna-vaccines-and-therapeutics-industry-market

Summary
The principle of an mRNA vaccine is to deliver mRNA to a target cell where it will be translated into a coded antigen, allowing for immunological recognition and promising protection. By using genetic material to encode antigens, new vaccines can be quickly created or modified at a very low cost. Another advantage of RNA vaccines is that they can be stable for long periods of time at room temperature, allowing for use in rural areas where refrigeration costs are high or non-existent.

The mRNA Vaccines and Therapeutics market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.

Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.

In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the mRNA Vaccines and Therapeutics industry.

Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.

In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.

The mRNA Vaccines and Therapeutics market can be split based on product types, major applications, and important countries as follows:

Key players in the global mRNA Vaccines and Therapeutics market covered in Chapter 12:
In-Cell-Art
Ethris
Argos Therapeutics
Precision NanoSystems
Moderna Therapeutics
Bayer
CRISPR Therapeutics
PhaseRx
BioNTech
MaxCyte
eTheRNA immunotherapies
CureVac
Boehringer Ingelheim
AstraZeneca
Janssen
RaNa Therapeutics
Novartis
Kernal Biologics
GlaxoSmithKline Vaccines
Intellia Therapeutics

In Chapter 4 and 14.1, on the basis of types, the mRNA Vaccines and Therapeutics market from 2015 to 2025 is primarily split into:

Standardization Of Cancer Treatment mRNA Vaccine
Individualized Cancer Treatment mRNA Vaccine
Infectious Disease Treatment mRNA Vaccine
Infection Prevention mRNA Vaccine

In Chapter 5 and 14.2, on the basis of applications, the mRNA Vaccines and Therapeutics market from 2015 to 2025 covers:

Hospital
Clinic
Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:

North America (Covered in Chapter 7 and 14)

United States

Canada

Mexico

Europe (Covered in Chapter 8 and 14)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 9 and 14)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 10 and 14)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 11 and 14)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Table of Content
1 mRNA Vaccines and Therapeutics Introduction and Market Overview

1.1 Objectives of the Study

1.2 Overview of mRNA Vaccines and Therapeutics

1.3 Scope of The Study

1.3.1 Key Market Segments

1.3.2 Players Covered

1.3.3 COVID-19’s impact on the mRNA Vaccines and Therapeutics industry

1.4 Methodology of The Study

1.5 Research Data Source

2 Executive Summary

2.1 Market Overview

2.1.1 Global mRNA Vaccines and Therapeutics Market Size, 2015 – 2020

2.1.2 Global mRNA Vaccines and Therapeutics Market Size by Type, 2015 – 2020

2.1.3 Global mRNA Vaccines and Therapeutics Market Size by Application, 2015 – 2020

2.1.4 Global mRNA Vaccines and Therapeutics Market Size by Region, 2015 – 2025

2.2 Business Environment Analysis

2.2.1 Global COVID-19 Status and Economic Overview

2.2.2 Influence of COVID-19 Outbreak on mRNA Vaccines and Therapeutics Industry Development

3 Industry Chain Analysis

3.1 Upstream Raw Material Suppliers of mRNA Vaccines and Therapeutics Analysis

3.2 Major Players of mRNA Vaccines and Therapeutics

3.3 mRNA Vaccines and Therapeutics Manufacturing Cost Structure Analysis

3.3.1 Production Process Analysis

3.3.2 Manufacturing Cost Structure of mRNA Vaccines and Therapeutics

3.3.3 Labor Cost of mRNA Vaccines and Therapeutics

3.4 Market Distributors of mRNA Vaccines and Therapeutics

3.5 Major Downstream Buyers of mRNA Vaccines and Therapeutics Analysis

3.6 The Impact of Covid-19 From the Perspective of Industry Chain

3.7 Regional Import and Export Controls Will Exist for a Long Time

3.8 Continued downward PMI Spreads Globally

4 Global mRNA Vaccines and Therapeutics Market, by Type

4.1 Global mRNA Vaccines and Therapeutics Value and Market Share by Type (2015-2020)

4.2 Global mRNA Vaccines and Therapeutics Production and Market Share by Type (2015-2020)

4.3 Global mRNA Vaccines and Therapeutics Value and Growth Rate by Type (2015-2020)

4.3.1 Global mRNA Vaccines and Therapeutics Value and Growth Rate of Standardization Of Cancer Treatment mRNA Vaccine
4.3.2 Global mRNA Vaccines and Therapeutics Value and Growth Rate of Individualized Cancer Treatment mRNA Vaccine
4.3.3 Global mRNA Vaccines and Therapeutics Value and Growth Rate of Infectious Disease Treatment mRNA Vaccine
4.3.4 Global mRNA Vaccines and Therapeutics Value and Growth Rate of Infection Prevention mRNA Vaccine
4.4 Global mRNA Vaccines and Therapeutics Price Analysis by Type (2015-2020)

5 mRNA Vaccines and Therapeutics Market, by Application

5.1 Downstream Market Overview

5.2 Global mRNA Vaccines and Therapeutics Consumption and Market Share by Application (2015-2020)

5.3 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate by Application (2015-2020)

5.3.1 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate of Hospital (2015-2020)
5.3.2 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate of Clinic (2015-2020)
5.3.3 Global mRNA Vaccines and Therapeutics Consumption and Growth Rate of Other (2015-2020)

6 Global mRNA Vaccines and Therapeutics Market Analysis by Regions

6.1 Global mRNA Vaccines and Therapeutics Sales, Revenue and Market Share by Regions

6.1.1 Global mRNA Vaccines and Therapeutics Sales by Regions (2015-2020)

6.1.2 Global mRNA Vaccines and Therapeutics Revenue by Regions (2015-2020)

6.2 North America mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

6.3 Europe mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

6.4 Asia-Pacific mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

6.5 Middle East and Africa mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

6.6 South America mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

7 North America mRNA Vaccines and Therapeutics Market Analysis by Countries

7.1 The Influence of COVID-19 on North America Market

7.2 North America mRNA Vaccines and Therapeutics Sales, Revenue and Market Share by Countries

7.2.1 North America mRNA Vaccines and Therapeutics Sales by Countries (2015-2020)

7.2.2 North America mRNA Vaccines and Therapeutics Revenue by Countries (2015-2020)

7.3 United States mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

7.4 Canada mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

7.5 Mexico mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

8 Europe mRNA Vaccines and Therapeutics Market Analysis by Countries

8.1 The Influence of COVID-19 on Europe Market

8.2 Europe mRNA Vaccines and Therapeutics Sales, Revenue and Market Share by Countries

8.2.1 Europe mRNA Vaccines and Therapeutics Sales by Countries (2015-2020)

8.2.2 Europe mRNA Vaccines and Therapeutics Revenue by Countries (2015-2020)

8.3 Germany mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

8.4 UK mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

8.5 France mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

8.6 Italy mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

8.7 Spain mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

8.8 Russia mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

9 Asia Pacific mRNA Vaccines and Therapeutics Market Analysis by Countries

9.1 The Influence of COVID-19 on Asia Pacific Market

9.2 Asia Pacific mRNA Vaccines and Therapeutics Sales, Revenue and Market Share by Countries

9.2.1 Asia Pacific mRNA Vaccines and Therapeutics Sales by Countries (2015-2020)

9.2.2 Asia Pacific mRNA Vaccines and Therapeutics Revenue by Countries (2015-2020)

9.3 China mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

9.4 Japan mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

9.5 South Korea mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

9.6 India mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

9.7 Southeast Asia mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

9.8 Australia mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

10 Middle East and Africa mRNA Vaccines and Therapeutics Market Analysis by Countries

10.1 The Influence of COVID-19 on Middle East and Africa Market

10.2 Middle East and Africa mRNA Vaccines and Therapeutics Sales, Revenue and Market Share by Countries

10.2.1 Middle East and Africa mRNA Vaccines and Therapeutics Sales by Countries (2015-2020)

10.2.2 Middle East and Africa mRNA Vaccines and Therapeutics Revenue by Countries (2015-2020)

10.3 Saudi Arabia mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

10.4 UAE mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

10.5 Egypt mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

10.6 Nigeria mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

10.7 South Africa mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

11 South America mRNA Vaccines and Therapeutics Market Analysis by Countries

11.1 The Influence of COVID-19 on Middle East and Africa Market

11.2 South America mRNA Vaccines and Therapeutics Sales, Revenue and Market Share by Countries

11.2.1 South America mRNA Vaccines and Therapeutics Sales by Countries (2015-2020)

11.2.2 South America mRNA Vaccines and Therapeutics Revenue by Countries (2015-2020)

11.3 Brazil mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

11.4 Argentina mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

11.5 Columbia mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

11.6 Chile mRNA Vaccines and Therapeutics Sales and Growth Rate (2015-2020)

12 Competitive Landscape

12.1 In-Cell-Art
12.1.1 In-Cell-Art Basic Information
12.1.2 mRNA Vaccines and Therapeutics Product Introduction
12.1.3 In-Cell-Art Production, Value, Price, Gross Margin 2015-2020
12.2 Ethris
12.2.1 Ethris Basic Information
12.2.2 mRNA Vaccines and Therapeutics Product Introduction
12.2.3 Ethris Production, Value, Price, Gross Margin 2015-2020
12.3 Argos Therapeutics
12.3.1 Argos Therapeutics Basic Information
12.3.2 mRNA Vaccines and Therapeutics Product Introduction
12.3.3 Argos Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.4 Precision NanoSystems
12.4.1 Precision NanoSystems Basic Information
12.4.2 mRNA Vaccines and Therapeutics Product Introduction
12.4.3 Precision NanoSystems Production, Value, Price, Gross Margin 2015-2020
12.5 Moderna Therapeutics
12.5.1 Moderna Therapeutics Basic Information
12.5.2 mRNA Vaccines and Therapeutics Product Introduction
12.5.3 Moderna Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.6 Bayer
12.6.1 Bayer Basic Information
12.6.2 mRNA Vaccines and Therapeutics Product Introduction
12.6.3 Bayer Production, Value, Price, Gross Margin 2015-2020
12.7 CRISPR Therapeutics
12.7.1 CRISPR Therapeutics Basic Information
12.7.2 mRNA Vaccines and Therapeutics Product Introduction
12.7.3 CRISPR Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.8 PhaseRx
12.8.1 PhaseRx Basic Information
12.8.2 mRNA Vaccines and Therapeutics Product Introduction
12.8.3 PhaseRx Production, Value, Price, Gross Margin 2015-2020
12.9 BioNTech
12.9.1 BioNTech Basic Information
12.9.2 mRNA Vaccines and Therapeutics Product Introduction
12.9.3 BioNTech Production, Value, Price, Gross Margin 2015-2020
12.10 MaxCyte
12.10.1 MaxCyte Basic Information
12.10.2 mRNA Vaccines and Therapeutics Product Introduction
12.10.3 MaxCyte Production, Value, Price, Gross Margin 2015-2020
12.11 eTheRNA immunotherapies
12.11.1 eTheRNA immunotherapies Basic Information
12.11.2 mRNA Vaccines and Therapeutics Product Introduction
12.11.3 eTheRNA immunotherapies Production, Value, Price, Gross Margin 2015-2020
12.12 CureVac
12.12.1 CureVac Basic Information
12.12.2 mRNA Vaccines and Therapeutics Product Introduction
12.12.3 CureVac Production, Value, Price, Gross Margin 2015-2020
12.13 Boehringer Ingelheim
12.13.1 Boehringer Ingelheim Basic Information
12.13.2 mRNA Vaccines and Therapeutics Product Introduction
12.13.3 Boehringer Ingelheim Production, Value, Price, Gross Margin 2015-2020
12.14 AstraZeneca
12.14.1 AstraZeneca Basic Information
12.14.2 mRNA Vaccines and Therapeutics Product Introduction
12.14.3 AstraZeneca Production, Value, Price, Gross Margin 2015-2020
12.15 Janssen
12.15.1 Janssen Basic Information
12.15.2 mRNA Vaccines and Therapeutics Product Introduction
12.15.3 Janssen Production, Value, Price, Gross Margin 2015-2020
12.16 RaNa Therapeutics
12.16.1 RaNa Therapeutics Basic Information
12.16.2 mRNA Vaccines and Therapeutics Product Introduction
12.16.3 RaNa Therapeutics Production, Value, Price, Gross Margin 2015-2020
12.17 Novartis
12.17.1 Novartis Basic Information
12.17.2 mRNA Vaccines and Therapeutics Product Introduction
12.17.3 Novartis Production, Value, Price, Gross Margin 2015-2020
12.18 Kernal Biologics
12.18.1 Kernal Biologics Basic Information
12.18.2 mRNA Vaccines and Therapeutics Product Introduction
12.18.3 Kernal Biologics Production, Value, Price, Gross Margin 2015-2020
12.19 GlaxoSmithKline Vaccines
12.19.1 GlaxoSmithKline Vaccines Basic Information
12.19.2 mRNA Vaccines and Therapeutics Product Introduction
12.19.3 GlaxoSmithKline Vaccines Production, Value, Price, Gross Margin 2015-2020
12.20 Intellia Therapeutics
12.20.1 Intellia Therapeutics Basic Information
12.20.2 mRNA Vaccines and Therapeutics Product Introduction
12.20.3 Intellia Therapeutics Production, Value, Price, Gross Margin 2015-2020

13 Industry Outlook

13.1 Market Driver Analysis

13.1.2 Market Restraints Analysis

13.1.3 Market Trends Analysis

13.2 Merger, Acquisition and New Investment

13.3 News of Product Release

14 Global mRNA Vaccines and Therapeutics Market Forecast

14.1 Global mRNA Vaccines and Therapeutics Market Value & Volume Forecast, by Type (2020-2025)

14.1.1 Standardization Of Cancer Treatment mRNA Vaccine Market Value and Volume Forecast (2020-2025)
14.1.2 Individualized Cancer Treatment mRNA Vaccine Market Value and Volume Forecast (2020-2025)
14.1.3 Infectious Disease Treatment mRNA Vaccine Market Value and Volume Forecast (2020-2025)
14.1.4 Infection Prevention mRNA Vaccine Market Value and Volume Forecast (2020-2025)
14.2 Global mRNA Vaccines and Therapeutics Market Value & Volume Forecast, by Application (2020-2025)

14.2.1 Hospital Market Value and Volume Forecast (2020-2025)
14.2.2 Clinic Market Value and Volume Forecast (2020-2025)
14.2.3 Other Market Value and Volume Forecast (2020-2025)
14.3 mRNA Vaccines and Therapeutics Market Analysis and Forecast by Region

14.3.1 North America Market Value and Consumption Forecast (2020-2025)

14.3.2 Europe Market Value and Consumption Forecast (2020-2025)

14.3.3 Asia Pacific Market Value and Consumption Forecast (2020-2025)

14.3.4 Middle East and Africa Market Value and Consumption Forecast (2020-2025)

14.3.5 South America Market Value and Consumption Forecast (2020-2025)

15 New Project Feasibility Analysis

15.1 Industry Barriers and New Entrants SWOT Analysis

15.1.1 Porter’s Five Forces Analysis

15.1.2 New Entrants SWOT Analysis

15.2 Analysis and Suggestions on New Project Investment

….Continued

View Detailed Table of Content @ https://www.htfmarketreport.com/reports/2822325-covid-19-outbreak-global-mrna-vaccines-and-therapeutics-industry-market

It’s vital you keep your market knowledge up to date. If you have a different set of players/manufacturers according to geography or needs regional or country segmented reports we can provide customization accordingly.

Contact Us:
CRAIG FRANCIS (PR & Marketing Manager)
[email protected]
Ph: +1 (206) 317 1218

Connect with us at LinkedIn | Facebook | Twitter

Tags

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
Close